-
Launch of MENOGON
-In June of this year Ferring launched its first product in the area of infertility, MENOGON® (menotropin) for the treatment…
0 -
New activities in Prague
-Ferring BV entered into a joint-venture with Léciva a.s., the largest pharmaceutical company in the Czech Republic at that time.
-
New worldwide subsidiaries
-During the 1990s, Ferring accelerated the opening of new subsidiaries in Eastern and Western Europe, South America, Asia, South Africa…
-
Frederik Paulsen Junior becomes Chairman
-The founder’s youngest son, Frederik Paulsen, became Chairman of the Ferring Group. At the same time Ferring established Ferring B.V.…
-
Launch of PENTASA
-Ferring launched PENTASA® (mesalazine) for the treatment of inflammatory bowel diseases. This product enabled the company to strengthen its position…
-
Launch of MINIRIN tablet
-The MINIRIN® tablet was the first peptide-based pharmaceutical to be successfully formulated for administration in tablet form.
-
Kiel Ferring Foundation
-Dr. Frederik Paulsen was one of the initiators of the Kiel Ferring Foundation, which, since its formation has awarded 20,000…
-
Continuous Expansion
-Ferring began forming global subsidiaries in Europe, North America and Southeast Asia.
-
Launch of GLYPRESSIN
-First registration and launch of GLYPRESSIN® (terlipressin), an analogue of vasopressin, which is used for the treatment of bleeding oesophageal…
-
New production site
-Ferring established its first production site outside Scandinavia in Kiel, Germany.
TIMELINES
TIMELINES